✦ LIBER ✦

P.2.a.010 Treatment of postpartum depression with psychotherapy and add-on sertraline: a double-blind, randomised, placebo-controlled study

✍ Scribed by M. Bloch; H. Meiboom; M. Lorberblat; I. Aharonov; I. Bluvshtein; S. Ben-Itzhak; S. Schreiber

Book ID: 118598283
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 75 KB
Volume: 21
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(11)70574-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A double-blind placebo-controlled multic

A double-blind placebo-controlled multicentre study of sertraline in the acute and continuation treatment of major depression

✍ JP Olie; KP Gunn; E Katz 📂 Article 📅 1997 🏛 Elsevier Science 🌐 French ⚖ 705 KB

P.2.a.015 Addition of atomoxetine for de

P.2.a.015 Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study

✍ D. Michelson; L.A. Adler; J.D. Amsterdam; D.L. Dunner; A.A. Nierenberg; F.W. Rei 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 77 KB

P-2-45 The treatment of dysthymia with s

P-2-45 The treatment of dysthymia with sertraline: A double-blind placebo-controlled trial in dysthymic outpatients without major depression

✍ J.D. Guelfi; R.L. Wiseman 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 271 KB

A randomised double-blind placebo-contro

A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures

✍ P. Loiseau; A.W.C. Yuen; B. Duché; T. Ménager; M.C. Arné-Bès 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 874 KB

Efficacy and safety of lamotrigine (LTG) as add-on therapy was assessed in a randomised double-blind placebo-controlled trial of this drug in 23 adult patients with refractory partial seizures. Fifteen patients showed an improvement on LTG treatment, with a greater than 50% decrease in total seizure

P.2.b.017 Onset of efficacy of ketamine

P.2.b.017 Onset of efficacy of ketamine in treatment-resistant depression: a double-blind, randomised, placebo-controlled, dose frequency study

✍ Singh, J.; Fedgchin, M.; Daly, E.; De Boer, P.; Cooper, K.; Lim, P.; Pinter, C.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Mirtazapine add-on therapy in the treatm

Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial

✍ Michael Berk; Clarissa S. Gama; Suresh Sundram; Harry Hustig; Les Koopowitz; Rus 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views

## Abstract ## Objective Schizophrenia is a multifaceted illness with positive, negative and cognitive symptom domains. Standard treatments often focus on positive symptoms and may not adequately relieve other symptoms. Previous studies have suggested a role for mirtazapine in schizophrenia, parti